|
Volumn 297, Issue 1, 2001, Pages 133-140
|
Dynamic dopamine-antagonist interactions at recombinant human dopamine D2short receptor: Dopamine-bound versus antagonist-bound receptor states
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN;
BENZAMIDE DERIVATIVE;
BROMERGURIDE;
BROMOCRIPTINE;
BUTACLAMOL;
CALCIUM;
CHLORPROMAZINE;
CLOZAPINE;
DOMPERIDONE;
DOPAMINE;
DOPAMINE 2 RECEPTOR;
DOPAMINE RECEPTOR BLOCKING AGENT;
EMONAPRIDE;
FLUPHENAZINE;
GUANINE NUCLEOTIDE BINDING PROTEIN;
HALOPERIDOL;
LISURIDE MALEATE;
NEUROLEPTIC AGENT;
OLANZAPINE;
PROPYLNORAPOMORPHINE;
RISPERIDONE;
S 14066;
SULPIRIDE;
TROPAPRIDE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
CALCIUM SIGNALING;
CHO CELL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG RECEPTOR BINDING;
GENETIC TRANSFECTION;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
RECEPTOR INTRINSIC ACTIVITY;
SITE DIRECTED MUTAGENESIS;
ANIMALS;
CALCIUM;
CHO CELLS;
CRICETINAE;
DOPAMINE;
DOPAMINE ANTAGONISTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
RECEPTORS, DOPAMINE D2;
RECOMBINANT PROTEINS;
|
EID: 0035082663
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (28)
|